Navigation Links
Oncos Therapeutics Granted Orphan Drug Designation for CGTG-102 in Soft Tissue Sarcoma (STS) by FDA and EMA
Date:7/31/2013

HELSINKI, Finland, July 31, 2013 /PRNewswire/ --

Oncos Therapeutics Ltd, a private, clinical-stage biotechnology company focused on the development and commercialization of targeted oncolytic immunotherapies for solid tumors, announced today that the United States Food and Drug Administration (FDA) and European Medicines Agency (EMA) have granted orphan drug designation for CGTG-102, a granulocyte-macrophage colony stimulating factor-coding oncolytic adenovirus (Ad5/3-D24-GMCSF) for the treatment of soft tissue sarcoma.

     (Logo: http://photos.prnewswire.com/prnh/20130731/630919)

"We are pleased to receive orphan drug designations for CGTG-102 from the two leading regulatory agencies in the world. These designations confirm the need for developing novel therapies for rare cancers and are an important step in the development of CGTG-102" ,said Frans Wuite, M.D., President and Chief Executive Officer of Oncos.

Orphan Drug Designation applies to drugs that seek to treat rare diseases or conditions for which there may be few adequate therapies. In USA, the designation will provide Oncos with the opportunity of seven years of marketing exclusivity, grant funding to defray costs of clinical trial expenses, tax credits for clinical research expenses and potential waiver of the FDA's application user fee. Similarly, incentives are provided for Europe by EMA, which include fee reductions on future activities and the potential for 10 years market exclusivity.

About Soft Tissue Sarcoma

Soft tissue sarcoma is estimated to affect 3-4 in 10,000 people in the EU and US. About 50% of soft tissue sarcomas are found in the early stage and advanced stage patients have an average overall survival of 13 months with today's standard of care. Several efforts to develop additional chemotherapeutics for STS have failed, including two produ
'/>"/>

SOURCE Oncos Therapeutics Ltd
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. OncoSec Medical Updates Analysis of Interim Data for Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
2. OncoSec Medical to Present at the HemOnc Today Melanoma and Cutaneous Malignancies Meeting in New York
3. OncoSec Medical to Present at the 25th Annual Roth Conference
4. OncoSec Medical Promotes Veronica Vallejo to Chief Financial Officer
5. OncoSec Medical to Present at the 15th Annual BIO CEO & Investor Conference
6. OncoSec Medical to Present at Noble Financial Capital Markets Ninth Annual Equity Conference on January 22
7. OncoSec Medical Announces $7.2 Million Public Offering
8. OncoSec Medical to Present Data at DNA Vaccines 2012 Conference
9. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
10. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
11. OncoSec to Present at Upcoming Healthcare and Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... The new report by ... applications, techniques, end users and Geography) Global Size, ... - 2020," indicates that the global DNA diagnostics ... a CAGR of 9.8% from 2014 to 2020. ... effectiveness over alternative diagnostic techniques are factors which ...
(Date:8/28/2014)... Aug. 28, 2014  In recognition of the increased ... from the flu, pneumonia, shingles and other illnesses, ... declared September to be Senior Vaccination Month. Because ... is important that adults ages 65 years and ... CVS pharmacists and MinuteClinic nurse practitioners and physician ...
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire/ ... market research report is available in ... Therapeutics in Asia-Pacific Markets to 2020 ... Unmet Need in Newly Diagnosed and ... http://www.reportlinker.com/p02343492/Glioblastoma-Multiforme-Therapeutics-in-Asia-Pacific-Markets-to-2020---Novel-Therapeutic-Approaches-Target-High-Unmet-Need-in-Newly-Diagnosed-and-Recurrent-GBM.html Glioblastoma ...
Breaking Medicine Technology:DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 2Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 3Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 5Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 6Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 7Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 8Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 9
... N.J., Oct. 17 Ten abstracts providing new,analyses of ... for,MIRCERA(R) will be presented at the upcoming 40th Annual ... Francisco on November 2 - 5,2007. Among the ... PROTOS, STRIATA and RUBRA, and correction studies,including ARCTOS and ...
... MOINES, Iowa, Oct. 16 Protocol Driven ... announced a partnership,with Hallmark Insights to provide ... users of the ConXus health improvement platform. ... fulfillment services,for reward points earned by participants ...
Cached Medicine Technology:New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting 2New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting 3New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting 4PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs 2
(Date:8/29/2014)... The Fresh Diet, America’s premier gourmet meal delivery ... meal plan. Originating from The Fresh Diet’s commitment to ... designed to satisfy customers seeking a convenient, worry-free option ... to the growing demand by customers for non-meat menu ... with 14% of Americans identifying vegetarian meals as ‘more ...
(Date:8/29/2014)... PA (PRWEB) August 29, 2014 As ... Cooper City, Fla., understands that there’s a direct connection ... the knees, hips and back. "Since conventional shoe inserts ... design a solution of my own," he said. , ... Orthotic provides better support for the foot in order ...
(Date:8/29/2014)... 29, 2014 Williams Rejuva Center is ... their Latham aesthetic office. Dr. Edwin Williams, known ... the first surgeons in the area to employ the ... technique is faster and safer than similar products available ... a noninvasive procedure , designed to dramatically improve ...
(Date:8/29/2014)... Glendale Botox experts at Glenoaks Laser Center are ... of September. This special offer features 10 free units of ... can take advantage of this special offer to completely transform ... work with patients to determine if Botox or Juvederm is ... , Botox is a treatment made from the botulinum toxin. ...
(Date:8/29/2014)... Dennis Thompson HealthDay Reporter ... research performed during the early days of the Ebola outbreak ... the virus mutates and spreads. Researchers report in the ... have now determined the following: The Ebola strains ... dating back to the very first recorded outbreak of Ebola ...
Breaking Medicine News(10 mins):Health News:The Fresh Diet America's #1 At-Home Meal Delivery Company, Debuts Fresh Vegetarian Meal Plan Offering All-Natural Ingredients 2Health News:The Fresh Diet America's #1 At-Home Meal Delivery Company, Debuts Fresh Vegetarian Meal Plan Offering All-Natural Ingredients 3Health News:Williams Revjuva Center Brings Micro-Needling to Latham 2Health News:Glenoaks Laser Center is Now Offering a Special Promotion on Botox for the Month of September 2Health News:Gene Research Yields Insights Into Ebola Virus 2Health News:Gene Research Yields Insights Into Ebola Virus 3
... have observed a high resolution camera which detects tumours ... been comparing mammography with a technique called scintimammography, which ... is good at distinguishing between malignant and benign tumours, ... limitation of this kind of camera is that it ...
... to Japanese researchers, genetic abnormalities bound with marijuana-activated ... a lead researcher, of the Okayama University, observed ... use can result in schizophrenia or a considerablelly ... of the greatest mental health challenges in the ...
... looked at data for treatment of sub-arachnoid haemorrhage (SAH) in ... by bleeding into the brain do best in hospitals dealing ... within the blood supply surrounding the brain's exterior. It can ... nearly 10,000 patients admitted to 300 emergency departments was scanned, ...
... of antidepressant, called venlafaxine,assists patients with social anxiety disorder. ... and dread in relation to meeting and talking with ... situations a huge problem. Many of those with SAD ... condition can be hard to treat. ,Researchers ...
... ,According to a recent study, spending time in an Indian ... in a new study, India, looked at how traditional healing ... Muthuswamy in South India has long been a healing centre ... during a short period in 1000 were enrolled in the ...
... observed that, people suffering from heat diseases are better off ... for a few it might prove too much.People who are ... safe to enjoy a game of golf.// Researchers at the ... male golfers, aged between 50 and 75, half of whom ...
Cached Medicine News:Health News:Gene glitches connecting pot with Schizophrenia 2
4.625 inches, curved blade 4 mm....
Alvis foreign body spud 4 3/4 inches, oval curette 1 x 3 mm with fine point....
DIX foreign body spud 4 3/4 inches, 1.7 x 15 mm blade....
In reversible handle for removing foreign bodies....
Medicine Products: